Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2018-05-01
2018-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Study of Oral Collagen Peptide on Skin Condition Improvement
NCT06847035
Effects of Bend Beauty's Anti-Aging Formula on Inflammatory Markers
NCT03862872
A Study to Assess the Effects of an Oral Dietary Supplement on Overall Facial Appearance Among Healthy Adult Women With Existing Skin Damage From Sun Exposure
NCT01787461
Evaluation of the Anti-aging Efficacy of Two Dietary Supplements
NCT06032598
Evaluation of the Effects of an Oral Supplementation Containing Hyaluronic Acid
NCT06774742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Beauty Image
Beauty Image
1.97g/package; 2 packages one day for 8 weeks
Placebo Control
Placebo Control
Placebo Control; 1.97g/package; 2 packages one day for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beauty Image
1.97g/package; 2 packages one day for 8 weeks
Placebo Control
Placebo Control; 1.97g/package; 2 packages one day for 8 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In general good health and good mental state;
* Willing to read, understand and able to sign the Informed Consent Form;
* Willing to comply with all study protocol requirements.
Exclusion Criteria
* Participation in any clinical test or cosmetic product test on skin within 30 days;
* Existence of neurodermatitis, pityriasis, seborrheic dermatitis or psoriasis capitis on test area;
* Use of any anti-inflammatory drugs in the past 2 months;
* A history of skin diseases such as psoriasis, eczema, psoriasis, skin cancer, etc.;
* IDDM: Insulin dependent diabetic patients;
* Current treatment for asthma or other chronic respiratory diseases;
* Undergoing anticancer chemotherapy in the past 6 months;
* Existence of any other health problems or chronic diseases;
* Use of retinoids, alpha hydroxyl acid, ortho-hydroxybenzoic acid, hydroquinone nearly within 3 months; or use of prescriptions (such as antibiotics, retinoids, alpha hydroxyl acid or steroids), oral contraceptives (Use of same contraceptives for 6 months excepted);
* Existence of the following conditions or factors that the Investigator believes may affect the response of the skin or the interpretation of the test results, including, but not limited to, diabetes, vascular disease, hepatitis, eczema, psoriasis.
28 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pharmanex
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nu Skin (China) Daily-use & Health Products CO., LTD
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C180201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.